Effect of a Single 5-mg Infusion of Zoledronic Acid on Bone Turnover Markers Versus Oral Risedronate (5 mg/day) Over 1 Year in Patients with Glucocorticoid-Induced Osteoporosis.

Sambrook, P.; Devogelaer, Jean-Pierre; Reginster, Jacques; Saag, K.; Roux, C.; Lau, C.; Papanastasiou, P.; Schoenborn-Kellenberger, O.; Maylandt, K.; Fashola, T.; Mesenbrink, P.; Reid, D.

Effect of a Single 5-mg Infusion of Zoledronic Acid on Bone Turnover Markers Versus Oral Risedronate (5 mg/day) Over 1 Year in Patients with Glucocorticoid-Induced Osteoporosis.

Sambrook, P.

;

Devogelaer, Jean-Pierre

;

Reginster, Jacques

;

Saag, K.

;

Reid, D.

;et.al.

(2008) 30th Annual Meeting of the American-Society-for-Bone-and-Mineral-Research — Location: Montreal (Canada) (12.September.2008)

Files

No attached file found for this publication.

Details

Authors

Sambrook, P.
Author
Devogelaer, Jean-PierreUCLouvain
Author
Reginster, JacquesUCLouvain
Author
Saag, K.
Author
Reid, D.
Author

Affiliations

Citations

APA
Chicago
FWB

Sambrook, P., Devogelaer, J.-P., Reginster, J., Saag, K., Roux, C., Lau, C., Papanastasiou, P., Schoenborn-Kellenberger, O., Maylandt, K., Fashola, T., Mesenbrink, P., & Reid, D. (2008). Effect of a Single 5-mg Infusion of Zoledronic Acid on Bone Turnover Markers Versus Oral Risedronate (5 mg/day) Over 1 Year in Patients with Glucocorticoid-Induced Osteoporosis. Journal of Bone and Mineral Research, 23, S464-S464. https://hdl.handle.net/2078.5/147697 (Original work published 2008)